https://dermfield.com/articles/non-adherence-drives-apparent-acne-treatment-failure-gpwer-says Derm Field en 2026-10-30T13:46:13.305Z Non-adherence drives apparent acne treatment failure, GPwER says https://dermfield.com/articles/p53-activation-with-navtemadlin-boosts-t-cell-killing-of-melanoma Derm Field en 2026-10-30T13:16:08.040Z p53 Activation With Navtemadlin Boosts T-Cell Killing of Melanoma https://dermfield.com/articles/surgery-predominates-in-uk-loco-regional-melanoma-cohort Derm Field en 2026-10-30T12:41:08.787Z Surgery predominates in UK loco-regional melanoma cohort https://dermfield.com/articles/56-of-hijab-wearing-women-in-michigan-survey-tie-hair-loss-to-head-covering Derm Field en 2026-10-30T12:36:12.904Z 56% of Hijab-Wearing Women in Michigan Survey Tie Hair Loss to Head Covering https://dermfield.com/articles/personalized-melanoma-vaccine-cuts-recurrence-or-death-risk-42 Derm Field en 2026-10-30T12:36:12.904Z Personalized melanoma vaccine cuts recurrence or death risk 42% https://dermfield.com/articles/personalised-melanoma-mrna-vaccine-on-track-approval Derm Field en 2026-10-30T12:36:12.904Z Personalised melanoma mRNA vaccine on track for 2026 approval https://dermfield.com/articles/decade-old-cnn-beats-frontier-ai-models-at-skin-cancer-diagnosis Derm Field en 2026-10-30T12:36:12.904Z Decade-Old CNN Beats Frontier AI Models at Skin Cancer Diagnosis https://dermfield.com/articles/puig-targets-8-billion-in-revenue-with-isdin-deal Derm Field en 2026-10-30T12:36:12.904Z Puig Targets €8 Billion in Revenue by 2032 With Isdin Deal https://dermfield.com/articles/moderna-merck-melanoma-vaccine-cuts-death-or-recurrence-42 Derm Field en 2026-10-30T12:36:12.904Z Moderna-Merck melanoma vaccine cuts death or recurrence 42% https://dermfield.com/articles/36-scalp-hair-loss-prompts-jak-inhibitor-for-alopecia-areata Derm Field en 2026-10-30T12:36:12.904Z 36% Scalp Hair Loss Prompts JAK Inhibitor for Alopecia Areata https://dermfield.com/articles/personalized-mrna-vaccine-cuts-melanoma-relapse-risk-42-in-phase-iii Derm Field en 2026-10-30T12:36:12.904Z Personalized mRNA Vaccine Cuts Melanoma Relapse Risk 42% in Phase III https://dermfield.com/articles/aclaris-50-million-offering-meets-positive-allergy-trial-data Derm Field en 2026-10-30T12:36:12.904Z Aclaris’ $50 Million Offering Meets Positive Allergy Trial Data https://dermfield.com/articles/personalised-melanoma-vaccine-cuts-death-or-recurrence-risk-by-42 Derm Field en 2026-10-30T12:36:12.904Z Personalised melanoma vaccine cuts death or recurrence risk by 42% https://dermfield.com/articles/phase-3-melanoma-vaccine-cuts-recurrence-or-death-risk-by-42 Derm Field en 2026-10-30T12:36:12.904Z Phase 3 melanoma vaccine cuts recurrence or death risk by 42% https://dermfield.com/articles/heat-source-removal-treats-89-5-of-bullous-erythema-ab-igne-cases Derm Field en 2026-10-30T12:36:12.904Z Heat Source Removal Treats 89.5% of Bullous Erythema Ab Igne Cases https://dermfield.com/articles/asia-pacific-panel-puts-jak-inhibitors-first-line-in-severe-alopecia Derm Field en 2026-10-30T12:36:12.904Z Asia-Pacific panel puts JAK inhibitors first-line in severe alopecia https://dermfield.com/articles/skinbench-finds-false-eye-puffiness-flags-in-95-to-100-of-images Derm Field en 2026-10-30T12:36:12.904Z SkinBench finds false eye-puffiness flags in 95% to 100% of images https://dermfield.com/articles/acne-stigma-linked-to-20-higher-depression-odds-in-teens Derm Field en 2026-10-30T12:36:12.904Z Acne stigma linked to 20% higher depression odds in teens https://dermfield.com/articles/personalized-mrna-vaccine-cuts-melanoma-recurrence-or-death-risk-by-42 Derm Field en 2026-10-30T12:36:12.904Z Personalized mRNA vaccine cuts melanoma recurrence or death risk by 42% https://dermfield.com/articles/29-2-complete-response-rate-with-lifileucel-plus-pembrolizumab Derm Field en 2026-10-30T12:36:12.904Z 29.2% complete response rate with lifileucel plus pembrolizumab https://dermfield.com/articles/vaccine-plus-keytruda-lowers-relative-risk-of-recurrence-or-death-42 Derm Field en 2026-10-30T12:36:12.904Z Vaccine plus Keytruda lowers relative risk of recurrence or death 42% https://dermfield.com/articles/tga-overhauls-sunscreen-spf-testing-after-16-of-20-products-failed-claims Derm Field en 2026-10-30T12:36:12.904Z TGA Overhauls Sunscreen SPF Testing After 16 of 20 Products Failed Claims https://dermfield.com/articles/melanoma-checkpoint-signatures-split-tumors-into-three-survival-classes Derm Field en 2026-10-30T12:36:12.904Z Melanoma Checkpoint Signatures Split Tumors Into Three Survival Classes https://dermfield.com/articles/glp-1-medicines-linked-to-37-higher-relative-alopecia-risk Derm Field en 2026-10-30T12:36:12.904Z GLP-1 Medicines Linked to 37% Higher Relative Alopecia Risk https://dermfield.com/articles/a-benign-biopsy-result-does-not-end-the-melanoma-workup Derm Field en 2026-10-30T12:36:12.904Z A Benign Biopsy Result Does Not End the Melanoma Workup https://dermfield.com/articles/melanoma-vaccine-trial-shows-12-2-point-recurrence-free-survival-gain Derm Field en 2026-10-30T12:36:12.904Z Melanoma Vaccine Trial Shows 12.2-Point Recurrence-Free Survival Gain https://dermfield.com/articles/medicares-2-000-hurdle-to-advanced-dermatology-care Derm Field en 2026-10-30T12:36:12.904Z Medicare’s $2,000 Hurdle to Advanced Dermatology Care https://dermfield.com/articles/twenty-ingredients-shortlisted-for-in-cosmetics-asia-awards Derm Field en 2026-10-30T12:36:12.904Z Twenty Ingredients Shortlisted for in-cosmetics Asia 2026 Awards https://dermfield.com/articles/l-oreal-q3-sales-rise-7-2-as-dermatological-beauty-grows-11-6 Derm Field en 2026-10-30T12:36:12.904Z L'Oréal Q3 Sales Rise 7.2% as Dermatological Beauty Grows 11.6% https://dermfield.com/articles/alive-but-broken-impaired-gut-bacteria-function-linked-to-obesity-and-atopy Derm Field en 2026-10-30T12:36:12.904Z Alive but broken: impaired gut bacteria function linked to obesity and atopy https://dermfield.com/articles/autumn-budget-18-000-rates-threshold-lift-3-9-wage-rise Derm Field en 2026-10-30T12:36:12.904Z 2026 Autumn Budget: £18,000 Rates Threshold Lift, 3.9% Wage Rise https://dermfield.com/articles/personalized-melanoma-vaccine-cuts-recurrence-or-death-risk-by-42 Derm Field en 2026-10-30T12:36:12.904Z Personalized melanoma vaccine cuts recurrence or death risk by 42% https://dermfield.com/articles/three-oral-candidates-could-change-hidradenitis-suppurativa-care Derm Field en 2026-10-30T12:36:12.904Z Three Oral Candidates Could Change Hidradenitis Suppurativa Care https://dermfield.com/articles/citi-keeps-80-target-as-it-questions-moderna-melanoma-vaccine Derm Field en 2026-10-30T12:36:12.904Z Citi Keeps $80 Target as It Questions Moderna Melanoma Vaccine https://dermfield.com/articles/autoimmune-skin-disease-raises-cv-risk-from-adolescence-congress-hears Derm Field en 2026-10-30T12:36:12.904Z Autoimmune Skin Disease Raises CV Risk From Adolescence, Congress Hears https://dermfield.com/articles/two-drug-trial-produces-two-thirds-tumor-shrinkage-in-melanoma Derm Field en 2026-10-30T12:36:12.904Z Two-drug trial produces two-thirds tumor shrinkage in melanoma https://dermfield.com/articles/3-year-nemolizumab-data-early-responders-hit-easi-90-and-lasting-itch-relief Derm Field en 2026-10-30T12:36:12.904Z 3-Year Nemolizumab Data: Early Responders Hit EASI-90 and Lasting Itch Relief https://dermfield.com/articles/cxcr4-maps-to-dermal-immune-cells-in-psoriasis-study Derm Field en 2026-10-30T12:36:12.904Z CXCR4 maps to dermal immune cells in psoriasis study https://dermfield.com/articles/moderna-melanoma-vaccine-cuts-recurrence-risk-42-in-phase-3 Derm Field en 2026-10-30T12:36:12.904Z Moderna Melanoma Vaccine Cuts Recurrence Risk 42% in Phase 3 https://dermfield.com/articles/personalized-mrna-vaccine-cuts-melanoma-recurrence-risk-by-42-percent Derm Field en 2026-10-30T12:36:12.904Z Personalized mRNA Vaccine Cuts Melanoma Recurrence Risk by 42 Percent https://dermfield.com/articles/l-oreal-says-glp-1-drugs-are-now-moving-skin-care-sales Derm Field en 2026-10-30T12:36:12.904Z L'Oréal Says GLP-1 Drugs Are Now Moving Skin Care Sales https://dermfield.com/articles/masseter-botox-left-hannah-berner-unable-to-smile-what-went-wrong Derm Field en 2026-10-30T12:36:12.904Z Masseter Botox Left Hannah Berner Unable to Smile: What Went Wrong https://dermfield.com/articles/nivea-sales-fall-4-9-in-q3-as-beiersdorf-s-derma-unit-grows-10-6 Derm Field en 2026-10-30T12:36:12.904Z Nivea Sales Fall 4.9% in Q3 as Beiersdorf's Derma Unit Grows 10.6% https://dermfield.com/articles/australia-proposes-stronger-spf-testing-and-claim-rules Derm Field en 2026-10-30T12:36:12.904Z Australia Proposes Stronger SPF Testing and Claim Rules